Analyst calls Orphazyme's 300 percent value jump "strange and noteworthy"
![Photo: BRENDAN MCDERMID/REUTERS / X90143](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12954303.ece/ALTERNATES/schema-16_9/doc7fndf2d1ts715xckeigc.jpg)
On Thursday, Danish biotech company Orphazyme experienced a dramatic value jump on the US stock exchange.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.